Recurrent venous thromboembolism and bleeding complications during anticoagulant treatment in patients with cancer and venous thrombosis

Blood

Volumn 100, Issue 10, 2002, Pages 3484-3488

  Prandoni, Paolo ^a,b,c   Lensing, Anthonie W A ^a,b,c,d   Piccioli, Andrea ^a,b,c   Bernardi, Enrico ^a,b,c   Simioni, Paolo ^a,b,c   Girolami, Bruno ^a,b,c   Marchiori, Antonio ^a,b,c   Sabbion, Paola ^a,b,c   Prins, Martin H ^a,b,c   Noventa, Franco ^a,b,c   Girolami, Antonio ^a,b,c  

^a Clinical Epidemiology Group   (Italy)

^b UNIVERSITY HOSPITAL OF PADOVA   (Italy)

^c UNIVERSITY OF AMSTERDAM   (Netherlands)

^d ACADEMIC MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

ANTICOAGULANT AGENT; HEPARIN; LOW MOLECULAR WEIGHT HEPARIN;

ADULT; AGED; ANTICOAGULANT THERAPY; ARTICLE; BLEEDING; CANCER; CANCER PATIENT; DISEASE ASSOCIATION; FEMALE; FOLLOW UP; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROSPECTIVE STUDY; RECURRENT DISEASE; RISK FACTOR; THROMBOEMBOLISM; TUMOR LOCALIZATION; VEIN THROMBOSIS;

EID: 0037111563     PISSN: 00064971     EISSN: None     Source Type: Journal    
DOI: 10.1182/blood-2002-01-0108     Document Type: Article

References (34)

1. Hull R, Raskob GE, Hirsh J, Sackett DL. A cost-effectiveness analysis of alternative approaches for long-term treatment of proximal venous thrombosis. JAMA. 1984;252:235-239.
2. Prandoni P, Lensing AWA, Cogo A, et al. The long-term clinical course of acute deep venous thrombosis. Ann Intern Med. 1996;125:1-7.
3. Carson JL, Kelley MA, Duff A, et al. The clinical course of pulmonary embolism. N Engl J Med. 1992;326:1240-1245.
4. Simioni P, Prandoni P, Lensing AWA, et al. Risk for subsequent venous thromboembolic complications in carriers of the prothrombin or the factor V gene mutation with a first episode of deep-vein thrombosis. Blood. 2000;96:3329-3333.
5. Khamashta MA, Cuadrado MJ, Mujic F, Taub NA, Hunt BJ, Hughes GRV. The management of thrombosis in the antiphospholipid-antibody syndrome. N Engl J Med. 1995;332:993-997.
6. Lensing AWA, Prandoni P, Prins HR, Büller HR. Deep-vein thrombosis. Lancet. 1999;353:479-485.
7. Ginsberg JS. Management of venous thromboembolism. N Engl J Med. 1996;335:1816-1828.
8. The Columbus Investigators. Low-molecular-weight heparin in the treatment of patients with venous thromboembolism. N Engl J Med. 1997;337:657-662.
9. Hutten BA, Prins MH, Gent M, Ginsberg J, Tijssen JGP, Büller HR. Incidence of recurrent thromboembolic and bleeding complications among patients with venous thromboembolism in relation to both malignancy and achieved international normalized ratio. J Clin Oncol. 2000;18:3078-3083.
10. Douketis JD, Foster GA, Crowther MA, Prins MH, Ginsberg JS. Clinical risk factors and timing of recurrent venous thromboembolism during the initial 3 months of anticoagulant therapy. Arch Intern Med. 2000;160:3431-3436.
11. Rickles FR, Edwards RL. Activation of blood coagulation in cancer: Trousseau's syndrome revisited. Blood. 1983;62:14-31.
12. Sack GH Jr, Levin J, Bell WR. Trousseau's syndrome and other manifestations of chronic disseminated coagulopathy in patients with neoplasms: Clinical, pathophysiologic and therapeutic features. Medicine (Baltimore). 1977;56:1-37.
13. Piccioli A, Prandoni P, Ewenstein BM, Goldhaber SZ. Cancer and venous thromboembolism. Am Heart J. 1996;132:850-855.
14. Zacharski LR, Henderson WG, Forman WB, et al. Bleeding complications from warfarin anticoagulation in patients with malignancy. J Med. 1985;16:535-561.
15. Gitter MJ, Jaeger TM, Petterson TM, Gersh BJ, Silverstein MD. Bleeding and thromboembolism during anticoagulant therapy: A population-based study in Rochester, Minnesota. Mayo Clin Proc. 1995;70:725-733.
16. Palareti G, Legnani C, Lee A, et al. A comparison of the safety and efficacy of oral anticoagulation for the treatment of venous thromboembolic disease in patients with or without malignancy. Thromb Haemost. 2000;84:805-810.
17. Bona RD, Sivjee KY, Hickey AD, Wallace DM, Wajcs SB. The efficacy and safety of oral anticoagulation in patients with cancer. Thromb Haemost. 1995;74:1055-1058.
18. van der Meer FJM, Rosendaal FR, Vandenbroucke JP, Briet E. Bleeding complications in oral anticoagulant therapy. Arch Intern Med. 1993;153:1557-1562.
19. UICC International Union Against Cancer. TNM Classification of Malignant Tumours. Hermanek P, Sobin LH, eds. Berlin: Springer, 1987.
20. Burger PC, Vogel PS, Green SB, Strike TA. Glioblastoma multiforme and anaplastic astrocytoma. Pathologic criteria and prognostic implications. Cancer. 1985;56:1106-1111.
21. Sokal JE, Baccarani M, Russo D, Tura S. Staging and prognosis in chronic myelogenous leukemia. Semin Hematol. 1988;25:49-61.
22. Binet JL, Auquier A, Dighiero G, et al. A new prognostic classification of chronic lymphocytic leukemia derived from a multivariate survival analysis. Cancer. 1981;48:198-206.
23. Shipp MA, Harrington DP. A predictive model for aggressive NHL: The International Non-Hodgkin's Lymphoma Prognostic Factors Project. N Engl J Med. 1993;329:987-994.
24. Durie BGM, Salmon SE. A clinical staging system for multiple myeloma. Cancer. 1975;36:842-854.
25. Prandoni P, Lensing AWA, Büller HR, et al. Comparison of subcutaneous low-molecular-weight heparin with intravenous standard heparin in proximal-vein thrombosis. Lancet. 1992;339:441-445.
26. Prandoni P, Lensing AWA, Büller HR, et al. Deep-vein thrombosis and the incidence of subsequent symptomatic cancer. N Engl J Med. 1992;327:1128-1133.
27. Koopman MMW, Prandoni P, Piovella F. Treatment of venous thrombosis with intravenous unfractionated heparin administered in the hospital as compared with subcutaneous low-molecular-weight heparin administered at home. N Engl J Med. 1996;334:682-687.
28. Cogo A, Lensing AWA, Wells PS, Prandoni P, Büller HR. Non-invasive diagnostic tests for the diagnosis of clinically suspected deep-vein thrombosis. Haemostasis. 1995;25:27-39.
29. Koopman MMW, Büller HR, ten Cate JW. Diagnosis of recurrent deep vein thrombosis. Haemostasis. 1995;25:49-57.
30. Kearon C, Hirsh J. The diagnosis of pulmonary embolism. Haemostasis. 1995;25:72-87.
31. Disseminated intravascular coagulation. Levi M, ten Cate H. N Engl J Med. 1999;341:586-592.
32. Palareti G, Leali N, Coccheri S, et al. Bleeding complications of oral anticoagulant treatment: An inception-cohort, prospective collaborative study (ISCOAT). Lancet. 1996;348:423-428.
33. Callander N, Rappaport SI. Trousseau's syndrome. West J Med. 1993;158:364-371.
34. Decousus H, Leizorovicz A, Parent F, et al. A clinical trial of vena cava filters in the prevention of pulmonary embolism in patients with proximal deep-vein thrombosis. N Engl J Med. 1998;338:409-415.